EARLY CLINICAL OUTCOMES FOLLOWING RELEX SMILE PRO WITH THE NEW VISUMAX 800
Published 2022
- 26th ESCRS Winter Meeting
Reference: FP25
| Type: Abstracts
| DOI:
10.82333/xcex-8b66
Authors:
Supriya Samak Sriganesh* 1
, Sri Ganesh 1
, Sheetal Brar 1
1Phaco and Refractive Surgery,Nethradhama Superspeciality Eye Hospital,Bangalore,India
Purpose
To evaluate the early clinical outcomes following ReLEx SMILE PRO using the Visumax 800 in terms of safety, efficacy and intraoperative complications
Setting
Nethradhama Superspecialty Eye Hospital, Bangalore
Methods
A total of 42 eyes of 21 patients (25.95 ± 2.85 years; mean age ± standard deviation) with a mean spherical equivalent of -3.79 ± 2.33 underwent the ReLEx SMILE Pro procedure using the Visumax 800 machine for correction of myopia. The clinical outcomes were evaluated on post operative day 1 with respect to safety, efficacy and adverse events.
Results
The average pre operative corrected distance visual acuity was -0.07 ± 0.03 logMar, average post operative uncorrected distance visual acuity -0.07 ± 0.06 logMar and corrected post operative distance visual acuity was 0.10± 0.08 logMar. The efficacy index was found to be 1.00 and safety index 1.50. The pre operative OSI was 0.5 and post operative day 1 OSI was 1.135 (p=0.000002). No complications were observed in any of the cases.
Conclusion
Immediate post-op results with the VisuMax 800 demonstrate excellent correction and good visual acuity in terms of efficacy. No eyes had two or more lines loss of CDVA, demonstrating a good safety profile. Quality of vision and interface clarity showed minimal increase in scatter, which is expected to improve over time.